8
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8883 |
Pizuglanstat
|
Others; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Others |
Pizuglanstat 是一种前列腺素 D 合酶抑制剂,对人造血前列腺素 D 合酶的IC50为 76 nM,可用于肌再生性疾病研究。 | |||
T7948 |
HPGDS inhibitor 2
GSK-2894631A |
PGE Synthase | Immunology/Inflammation |
HPGDS inhibitor 2 (GSK-2894631A) 是高效的造血前列腺素 D 合成酶(H-PGDS)选择性抑制剂(IC50:9.9 nM)。 | |||
T1804 |
HPGDS inhibitor 1
HPGDS-inhibitor-1 |
PGE Synthase | Immunology/Inflammation |
HPGDS inhibitor 1 是口服具有活性的HPGDS 选择性抑制剂,在酶和细胞分析中的IC50值分别为 0.6 nM 和 32 nM,但对 L-PGDS、mPGES、COX-1、COX-2 、5-LOX 无抑制作用。 | |||
T24870 |
TFC-007
TFC007 |
||
TFC-007 is an inhibitor of hematopoietic prostaglandin D synthase. | |||
T15503 |
HQL-79
|
Others | Others |
HQL-79 is a selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor. It inhibits the synthesis of PGD2 and acts as an anti-allergic agent (Kd: 0.8 μM and IC50: 6 μM). It also shows no obvious effect on COX-1, COX-2, m-P | |||
T38350 |
TAS 205
|
||
TAS 205 is an inhibitor of hematopoietic prostaglandin D synthase (H-PGDS; IC50= 55.8 nM).1It is selective for H-PGDS over lipocalin-type PGDS (L-PGDS) at 100 μM, as well as over enzyme and receptor panels at 10 μM. TAS 205 inhibits production of prostaglandin D2induced by A23187 in KU812 human and RBL-2H3 rat basophils with IC50values of 78.3 and 181.3 nM, respectively. It inhibits ovalbumin-induced nasal lavage fluid eosinophil infiltration and late-phase nasal obstruction in an ovalbumin-sens... | |||
T61250 | HPGDS inhibitor 3 | ||
HPGDS inhibitor 3 is a powerful oral compound that selectively inhibits the hematopoietic prostaglandin D synthase (H-PGDS). With an IC50 value of 9.4 nM and EC50 of 42 nM, it demonstrates high potency in peripherally restricting H-PGDS. Moreover, HPGDS inhibitor 3 exhibits excellent selectivity with no associated central nervous system toxicity. This compound also possesses favorable pharmacokinetic properties in mouse, rat, and dog models. Additionally, HPGDS inhibitor 3 displays noteworthy an... | |||
T41267 |
PROTAC(H-PGDS)-7
|
||
PROTAC(H-PGDS)-7 是一种有选择性的、有效的小分子造血前列腺素 D 合酶 (H-PGDS)PROTAC 降解剂,在 KU812细胞中展现出降解活性,DC50为 17.3 pM。PROTAC(H-PGDS)-7是一种类药化合物,能有效抑制前列腺素 D2 (PGD2)的产生,抑制炎症因子重生作用。PROTAC(H-PGDS)-7是治疗 DMD 和其他H-PGDS 相关疾病的候选化合物。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04077 |
HPGDS/PGD2 Protein, Human, Recombinant (His)
hematopoietic prostaglandin D... |
Human | E. coli |
HPGDS/PGD2 Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 24.2 kDa and the accession number is O60760. | |||
TMPJ-00690 |
PGDS Protein, Human, Recombinant
Glutathione-Requiring Prostaglandin D<... |
Human | E. coli |
Hematopoietic Prostaglandin D Synthase (HPGDS) belongs to the GST superfamily and Sigma family. HPGDS contains one GST C-terminal domain and one GST N-terminal domain. HPGDS is highly expressed in adipose tissue, macrophages, and placenta, and it exists in the form of homodimer in living body. HPGDS is a cytosolic enzyme that isomerizes PGH(2). HPGDS is a bifunctional enzyme that catalyzes both the conversion of PGH2 to PGD2 and also shows low glutathione-peroxidase activity towards cumenehydrop... |